Avid Bioservices Highlights New Bioassay Capabilities to Support Phase III and Commercial-Stage Development Programs
14 mai 2013 11h00 HE | Avid Bioservices
TUSTIN, CA--(Marketwired - May 14, 2013) - Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc., today announced that its recent success in qualifying an...